High study participation but diverging adherence levels: qualitatively unpacking PrEP use among adolescent girls and young women over two years in Eastern Cape, South Africa

被引:4
作者
Krogstad Mudzingwa, Emily [1 ,2 ]
de Vos, Lindsey [3 ]
Atujuna, Millicent [1 ]
Fynn, Lauren [1 ]
Mugore, Matinatsa [4 ]
Mabandla, Selly [5 ]
Hosek, Sybil [6 ,7 ]
Celum, Connie [8 ,9 ]
Bekker, Linda-Gail [1 ]
Daniels, Joseph [10 ]
Medina-Marino, Andrew [1 ,11 ]
机构
[1] Univ Cape Town, Desmond Tutu Hlth Fdn, Desmond Tutu HIV Ctr, 3 Woodlands Rd, ZA-7915 Cape Town, South Africa
[2] Univ Connecticut, Inst Collaborat Hlth Intervent & Policy, Storrs, CT USA
[3] Fdn Profess Dev, Res Unit, Buffalo City Metro, Eastern Cape Pr, South Africa
[4] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA
[5] Eastern Cape Prov Dept Hlth, HIV AIDS STIs & TB Directorate, Buffalo City Hlth Dist, Bisho, South Africa
[6] John H Stroger Jr Hosp Cook Cty, Dept Psychiat, Chicago, IL USA
[7] John H Stroger Jr Hosp Cook Cty, Div Infect Dis, Chicago, IL USA
[8] Univ Washington, Dept Global Hlth, Seattle, WA USA
[9] Univ Washington, Dept Epidemiol, Seattle, WA USA
[10] Arizona State Univ, Edson Coll Nursing & Hlth Innovat, Phoenix, AZ USA
[11] Univ Penn, Perelman Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA
关键词
Pre-exposure prophylaxis; South Africa; Adherence; HIV prevention; Adolescent girls and young women; PREEXPOSURE PROPHYLAXIS; HIV-INFECTION; ANTIRETROVIRAL PROPHYLAXIS; TENOFOVIR; MEN;
D O I
10.1007/s10865-023-00462-2
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
In Southern and Eastern Africa, initiation of daily oral pre-exposure prophylaxis (PrEP) for HIV prevention has been high among adolescent girls and young women (AGYW) offered PrEP. However, persistence and prevention-effective use of PrEP among this critical group continues to be a challenge. We conducted a qualitative sub-study of AGYW from the Community PrEP Study in Eastern Cape Province, South Africa who had high rates of pick up for monthly PrEP refills over two years, but differing levels of PrEP adherence based on tenofovir-diphosphate (TFV-DP) measurements in dried blood spots (DBS). Contrasting 22 AGYW with low versus high levels of TFV-DP in DBS, we qualitatively explored factors which influenced PrEP persistence vs. non-persistence, unique patterns of PrEP use (e.g., discarding or stockpiling), and participant recommendations for improving AGYW prevention-effective use of PrEP in the future. Results showed that PrEP misconceptions and mistrust among participants' social networks negatively influenced adherence. In comparison, supportive families and/or partners and personal trust that PrEP works positively influenced adherence. Those with low adherence described being motivated to come to the site for other study benefits (e.g., reimbursement money, snacks, sanitary pads) and discarding PrEP to avoid stigma associated with being seen with pills. Future PrEP implementation strategies should focus on involving families and partners in PrEP support for AGYW and minimizing PrEP stigma at a community level.Trial registration NCT03977181. Retrospectively registered on June 6, 2019.
引用
收藏
页码:320 / 333
页数:14
相关论文
共 37 条
  • [1] Experiences with HPTN 067/ADAPT Study-Provided Open-Label PrEP Among Women in Cape Town: Facilitators and Barriers Within a Mutuality Framework
    Amico, K. Rivet
    Wallace, Melissa
    Bekker, Linda-Gail
    Roux, Surita
    Atujuna, Millicent
    Sebastian, Elaine
    Dye, Bonnie J.
    Elharrar, Vanessa
    Grant, Robert M.
    [J]. AIDS AND BEHAVIOR, 2017, 21 (05) : 1361 - 1375
  • [2] Intracellular Tenofovir-Diphosphate and Emtricitabine-Triphosphate in Dried Blood Spots following Directly Observed Therapy
    Anderson, Peter L.
    Liu, Albert Y.
    Castillo-Mancilla, Jose R.
    Gardner, Edward M.
    Seifert, Sharon M.
    McHugh, Cricket
    Wagner, Theresa
    Campbell, Kayla
    Morrow, Mary
    Ibrahim, Mustafa
    Buchbinder, Susan
    Bushman, Lane R.
    Kiser, Jennifer J.
    MaWhinney, Samantha
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (01)
  • [3] [Anonymous], 2022, Dedoose Version 9.0.46
  • [4] Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women
    Baeten, J. M.
    Donnell, D.
    Ndase, P.
    Mugo, N. R.
    Campbell, J. D.
    Wangisi, J.
    Tappero, J. W.
    Bukusi, E. A.
    Cohen, C. R.
    Katabira, E.
    Ronald, A.
    Tumwesigye, E.
    Were, E.
    Fife, K. H.
    Kiarie, J.
    Farquhar, C.
    John-Stewart, G.
    Kakia, A.
    Odoyo, J.
    Mucunguzi, A.
    Nakku-Joloba, E.
    Twesigye, R.
    Ngure, K.
    Apaka, C.
    Tamooh, H.
    Gabona, F.
    Mujugira, A.
    Panteleeff, D.
    Thomas, K. K.
    Kidoguchi, L.
    Krows, M.
    Revall, J.
    Morrison, S.
    Haugen, H.
    Emmanuel-Ogier, M.
    Ondrejcek, L.
    Coombs, R. W.
    Frenkel, L.
    Hendrix, C.
    Bumpus, N. N.
    Bangsberg, D.
    Haberer, J. E.
    Stevens, W. S.
    Lingappa, J. R.
    Celum, C.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (05) : 399 - 410
  • [5] PrEP uptake, persistence, adherence, and effect of retrospective drug level feedback on PrEP adherence among young women in southern Africa: Results from HPTN 082, a randomized controlled trial
    Celum, Connie
    Hosek, Sybil
    Tsholwana, Mandisa
    Kassim, Sheetal
    Mukaka, Shorai
    Dye, Bonnie J.
    Pathak, Subash
    Mgodi, Nyaradzo
    Bekker, Linda-Gail
    Donnell, Deborah J.
    Wilson, Ethan
    Yuha, Krista
    Anderson, Peter L.
    Agyei, Yaw
    Noble, Heather
    Rose, Scott M.
    Baeten, Jared M.
    Fogel, Jessica M.
    Adeyeye, Adeola
    Wiesner, Lubbe
    Rooney, James
    Delany-Moretlwe, Sinead
    [J]. PLOS MEDICINE, 2021, 18 (06)
  • [6] Incentives conditioned on tenofovir levels to support PrEP adherence among young South African women: a randomized trial
    Celum, Connie L.
    Gill, Katherine
    Morton, Jennifer F.
    Stein, Gabrielle
    Myers, Laura
    Thomas, Katherine K.
    McConnell, Margaret
    van der Straten, Ariane
    Baeten, Jared M.
    Duyver, Menna
    Mendel, Eve
    Naidoo, Keshani
    Dallimore, Jacqui
    Wiesner, Lubbe
    Bekker, Linda-Gail
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2020, 23 (11)
  • [7] Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial
    Choopanya, Kachit
    Martin, Michael
    Suntharasamai, Pravan
    Sangkum, Udomsak
    Mock, Philip A.
    Leethochawalit, Manoj
    Chiamwongpaet, Sithisat
    Kitisin, Praphan
    Natrujirote, Pitinan
    Kittimunkong, Somyot
    Chuachoowong, Rutt
    Gvetadze, Roman J.
    McNicholl, Janet M.
    Paxton, Lynn A.
    Curlin, Marcel E.
    Hendrix, Craig W.
    Vanichseni, Suphak
    [J]. LANCET, 2013, 381 (9883) : 2083 - 2090
  • [8] Corneli AL, 2015, JAIDS-J ACQ IMM DEF, V68, P578, DOI 10.1097/QAI.0000000000000525
  • [9] FEM-PrEP: Adherence Patterns and Factors Associated With Adherence to a Daily Oral Study Product for Pre-exposure Prophylaxis
    Corneli, Amy L.
    Deese, Jennifer
    Wang, Meng
    Taylor, Doug
    Ahmed, Khatija
    Agot, Kawango
    Lombaard, Johan
    Manongi, Rachel
    Kapiga, Saidi
    Kashuba, Angela
    Van Damme, Lut
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2014, 66 (03) : 324 - 331
  • [10] Daniels J, 2023, PLOS GLOB PUBL HLTH, V3, DOI 10.1371/journal.pgph.0000636